Acromegaly: What constitutes optimal therapy?

被引：26

作者：

Frohman, LA

机构：

来源：

关键词：

D O I：

10.1210/jc.81.2.443

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：443 / 445

页数：3

共 22 条

[1] EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION
ALEXANDER, L
APPLETON, D
HALL, R
ROSS, WM
WILKINSON, R
[J]. CLINICAL ENDOCRINOLOGY, 1980, 12 (01) : 71 - 79
[2] DOES TREATMENT OF ACROMEGALY AFFECT LIFE EXPECTANCY
BATES, AS
VANTHOFF, W
JONES, JM
CLAYTON, RN
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (01): : 1 - 5
[3] BENGTSSON BA, 1988, ACTA MED SCAND, V223, P327
[4] RISK OF 2ND BRAIN-TUMOR AFTER CONSERVATIVE SURGERY AND RADIOTHERAPY FOR PITUITARY-ADENOMA
BRADA, M
FORD, D
ASHLEY, S
BLISS, JM
CROWLEY, S
MASON, M
RAJAN, B
TRAISH, D
[J]. BRITISH MEDICAL JOURNAL, 1992, 304 (6838) : 1343 - 1346
[5] BURNER JOE, 1990, CLIN ENDOCRINOL OXF, V32, P65
[6] FACTORS CONTROLLING BLOOD-CONCENTRATION OF SOMATOMEDIN-C
CLEMMONS, DR
VANWYK, JJ
[J]. CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1984, 13 (01): : 113 - 143
[7] DINN JJ, 1985, Q J MED, V57, P833
[8] OCTREOTIDE TREATMENT OF ACROMEGALY - A RANDOMIZED, MULTICENTER STUDY
EZZAT, S
SNYDER, PJ
YOUNG, WF
BOYAJY, LD
NEWMAN, C
KLIBANSKI, A
MOLITCH, ME
BOYD, AE
SHEELER, L
COOK, DM
MALARKEY, WB
JACKSON, I
VANCE, ML
THORNER, MO
BARKAN, A
FROHMAN, LA
MELMED, S
[J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (09) : 711 - 718
[9] SURGICAL-MANAGEMENT OF ACROMEGALY
FAHLBUSCH, R
HONEGGER, J
BUCHFELDER, M
[J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1992, 21 (03) : 669 - 692
[10] FROHMAN LA, 1996, IN PRESS ONCOGENESIS